The Additional Role of Symptom-Reflux Association Analysis of Diagnosis of Gastroesophageal Reflux Disease Using Bravo Capsule pH Test.
10.4166/kjg.2017.70.4.169
- Author:
Kyoungwon JUNG
1
;
Moo In PARK
;
Seun Ja PARK
;
Won MOON
;
Sung Eun KIM
;
Jae Hyun KIM
Author Information
1. Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea. mipark@kosinmed.or.kr
- Publication Type:Original Article
- Keywords:
Bravo capsule pH test;
Gastroesophageal reflux disease;
Symptom-reflux association
- MeSH:
Diagnosis*;
Esophageal pH Monitoring;
Gastroesophageal Reflux*;
Humans;
Hydrogen-Ion Concentration*;
Hypersensitivity;
Proton Pumps;
Retrospective Studies
- From:The Korean Journal of Gastroenterology
2017;70(4):169-175
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND/AIMS: Since the development of ambulatory esophageal pH monitoring test to diagnose gastroesophageal reflux disease (GERD), several parameters have been introduced. The aim of this study was to assess whether using the symptom index (SI), symptom sensitivity index (SSI), and symptom association probability (SAP), in addition to the DeMeester score (DS), would be useful for interpreting the Bravo pH monitoring test. METHODS: A retrospective study, which included 68 patients with reflux symptoms refractory to proton pump inhibitor (PPI) therapy who underwent a Bravo capsule pH test between October 2006 and May 2015, was carried out. Acid reflux parameters and symptom reflux association parameters were analyzed. RESULTS: The median percent time of total pH<4 and DS were 2.90% (interquartile range [IQR] 1.13–6.03%) and 11.10 (IQR 4.90–22.80), respectively. According to the analysis of the day-to-day variation in percent time of total pH<4 (r=0.724) and DS (r=0.537), there was a significant correlation between Day 1 and Day 2. The positive rate of Bravo test according to DS was 27 (39.7%). Although thirty patients experienced symptoms during the test, there were no significant differences of reflux parameters compared with other patients. In the symptom group, 7 patients (23.3%) were identified as having negative DS and an abnormal symptom-related index. There were no significant test-related complications. CONCLUSIONS: In addition to the analysis of traditional acid parameters of the Bravo capsule pH test, diagnosis of GERD, including reflux hypersensitivity, can be improved by performing an analysis of the symptom-reflux association and of the day-to-day variation.
